Mutations that disable ARID1A occur in several cancers, including gastric cancer, hepatocyte cancer, breast cancer, and pancreatic cancer, and ARID1A mutations interfere with tumor suppression and cause carcinogenesis through other mechanisms [37,40]. Here, ARID1A is linked to cancer.